News For Placebo


Retrophin Announces Topline Results from Phase 3 FORT Study of Fosmetpantotenate in Patients with PKAN - BioSpace

Retrophin Announces Topline Results from Phase 3 FORT Study of Fosmetpantotenate in Patients with PKAN  BioSpace

Published: Aug 22, 2019. logo. FORT Study did not achieve its primary or secondary endpoints; Company to host conference call and webcast today at 8:30 a.m. ...

Google 8/23/2019 8:24:43 AM

High blood pressure: Three drinks proven to lower your reading - Express

High blood pressure: Three drinks proven to lower your reading  Express

HIGH blood pressure is a common health condition where the pressure inside the arteries is higher than it should be, and left untreated, the condition can lead to ...

Google 8/23/2019 7:58:00 AM

Clinical Trial Participation Reduces Alcohol Intake, Improves HIV Outcomes in Women Regardless of Treatment Type - AJMC.com Managed Markets Network

Clinical Trial Participation Reduces Alcohol Intake, Improves HIV Outcomes in Women Regardless of Treatment Type  AJMC.com Managed Markets Network

Women participating in a randomized clinical trial were able to significantly reduce their alcohol intake regardless of medication assignment and subsequently ...

Google 8/22/2019 8:29:33 PM

Antipsychotics Cause Short-Term Somatic Serious Adverse Events - Psychiatry Advisor

Antipsychotics Cause Short-Term Somatic Serious Adverse Events  Psychiatry Advisor

Researchers found data that showed in older patients with schizophrenia that concurrently somatic serious adverse events occurred independent of treatment ...

Google 8/22/2019 7:51:00 PM

Stimulant Medication With Evening Dosing to Address Early-Morning Functioning Impairments in ADHD - Pharmacy Times

Stimulant Medication With Evening Dosing to Address Early-Morning Functioning Impairments in ADHD  Pharmacy Times

This article was sponsored by Ironshore Pharmaceuticals Inc. Please see Full Prescribing Information, including Boxed Warning. Attention Deficit Hyperactivity ...

Google 8/22/2019 6:12:48 PM

Satsuma Pharmaceuticals Announces First Patient Dosed in EMERGE™, a Phase 3 Efficacy Trial of STS101 for the Acute Treatment of Migraine - Yahoo Finance

Satsuma Pharmaceuticals Announces First Patient Dosed in EMERGE™, a Phase 3 Efficacy Trial of STS101 for the Acute Treatment of Migraine  Yahoo Finance

SAN FRANCISCO , Aug. 22, 2019 /PRNewswire/ -- Satsuma Pharmaceuticals, Inc. ("Satsuma" or "the Company"), a clinical-stage biopharmaceutical company, ...

Google 8/22/2019 5:26:00 PM

UMB Cardiologist Co-Authors Omega-3 Science Advisory - UMB News

UMB Cardiologist Co-Authors Omega-3 Science Advisory  UMB News

Taking a prescription omega-3 fatty acid capsule is an effective way of lowering moderately elevated levels of triglycerides (a type of fat in the blood) and ...

Google 8/22/2019 5:09:57 PM

Pressure points for headaches: Locations, effectiveness, and tips - Medical News Today

Pressure points for headaches: Locations, effectiveness, and tips  Medical News Today

Acupressure is a form of complementary or alternative medicine. Read about research on the efficacy of acupressure for headache, and learn some simple ...

Google 8/22/2019 5:06:13 PM

 1 2 3 4 5  ...